FDA网站药品安全信息发布对我国启示  

The enlightenment of FDA drug safety information release for our country

作　　者：樊迪[1] 

机构地区：[1]中国药科大学高等职业技术学院,江苏南京211198

出　　处：《中国医院药学杂志》2014年第13期1134-1138,共5页Chinese Journal of Hospital Pharmacy

摘　　要：完善我国CFDA网站药品安全信息发布,对指导临床安全用药、避免药品不良反应(ADR)重复发生起重要作用。通过分析我国CFDA网站药品安全信息发布存在的问题,并分析美国FDA网站药品安全信息发布的特点,提出完善建议。我国应借鉴美国经验并结合我国国情,构建药品安全信息专页并从安全信息发布内容、渠道、沟通、宣传4个方面完善我国CFDA网站药品安全信息发布体系。Improving the security of drug information release in China CFDA website, to guide the clinical medication safety and to avoid repetitive ADR occurred, plays an important role in the safety of drug administration. By analyzing the problems existing in the security of drug information release in China CFDA website, and analyzing the characteristics of American FDA website drug safety information, a sound proposal was put forward. China should learn from the experience of USA combined with Chings national conditions, to establish drug safety information page and to improve the drug safety information release system in China CFDA website from the following four aspects., safety information publication, security information channels, communication and publicity.

关 键 词：FDA网站 CFDA网站 药品安全信息专页 药品安全信息 

分 类 号：G202[文化科学—传播学]